The global infectious disease biomarker testing market is witnessing a significant flux with regard to the recent advancements that have already taken place and are currently invading the market space. Additionally, with the entry of large number of companies in the market and launch of new product lines, the market represents massive potential to grow at an unprecedented double-digit growth rate. Factors such as increasing prevalence of infectious diseases, rapidly growing aging population that is more susceptible to disease, rising healthcare awareness, and the increasing involvement of patients in personal healthcare are collectively driving the growth the global infectious disease biomarker testing market. Further, technological advancements improving the ability to analyze the increasing number of biomarkers coupled with the augmenting demand for biomarker tests to diagnose various types of infectious diseases are some of the prominent driving factors accelerating the growth of the market.

1. Product Definition 

2. Scope of the Work 

3. Research Methodology 

4. Market Overview 

5. Market Dynamics

6. Industry Insights

7. Competitive Landscape 

8. Global Infectious Disease Biomarker Testing Market (by Product) 

9. Global Infectious Disease Biomarker Testing Market (by Application) 

10. Global Infectious Disease Biomarker Testing Market (by Technology)

11. Global Infectious Disease Biomarker Testing Market (by Pathogen) 

12. Global Infectious Disease Biomarker Testing Market (by End User) 

13. Global Infectious Disease Biomarker Testing Market (by Region)

14. Company Profiles